AbstractFirst-line multiple myeloma treatment has evolved from melphalan–prednisone to quadruplet regimens incorporating proteasome inhibitors, immunomodulatory drugs, anti-CD38 monoclonal antibodies, ...
To help defray the rising costs of initial manuscript screening and publication, the AACR journals levy fees as detailed herein. Authors are required to confirm at the time of submission that they ...
1Department of Gastroenterology, Ajou University School of Medicine, Suwon, Republic of Korea. 2BK21 R&E Initiative for Advanced Precision Medicine, Ajou University School of Medicine, Suwon, Republic ...
California-based biopharmaceutical company Gilead Sciences signed a licensing deal with China’s Genhouse Bio for the latter’s MAT2A inhibitor GH31. Gilead will pay $80 million up front for worldwide ...
Abstract. Lipid metabolism reprogramming modulates the tumor microenvironment (TME) and alters the function of immune cells, including tumor-infiltrating lymphocytes (TIL). Although lipids can enhance ...
1Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York. 2Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results